Source: Business Wire

Press Release: Synta : Synta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal Pharmaceuticals

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. ("Synta") (NASDAQ: SNTA) announced today that the annual meeting of stockholders to approve, among other things, the merger agreement with Madrigal Pharmaceuticals will be held on July 21, 2016, at 9:00 a.m. Eastern Time, for stockholders of record as of the close of business on May 31, 2016. The annual meeting will be held at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, Massachus

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Chen Schor's photo - President & CEO of Synta

President & CEO

Chen Schor

CEO Approval Rating

62/100

Read more